Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
Prolanta is a prolactin-based peptide containing a G129R mutation that acts as an antagonist of the prolactin receptor, leading to increased autophagy and cell death, and potentially resulting in decreased tumor growth (PMID: 24703838).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|